Pharmaceuticals, Inc. (NASDAQ: IRWD) and Actavis
plc (NYSE: ACT) announced today that the following
linaclotide-related data will be presented during the American College
of Gastroenterology 2014 Annual Scientific Meeting in Philadelphia,
October 17 through October 22, 2014.
Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appointment
of Thomas Graney as chief financial officer (CFO) and senior vice
president of finance and corporate strategy, and the appointment of Lisa
Adler as senior vice president of corporate communications.
Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update
at the Morgan Stanley Global Healthcare Conference on Wednesday,
September 10, 2014 at 8:00 a.m. Eastern Time at the Grand Hyatt New York.
By Therese Poletti, MarketWatch
Amazon.com Inc. (AMZN) reported a greater-than-expected loss in the second quarter, partly due to an increase in capital spending, but a deceleration in revenue at its cloud-services business was also causing some concerns among investors.
By Laura He, MarketWatch
HONG KONG (MarketWatch) -- Although the iPhone 6 is assembled in mainland China, Apple fans there won't be able to buy the device on the day of its global launch, slated for next Friday.
By Jennifer Booton, MarketWatch
NEW YORK (MarketWatch) -- Apple (AAPL) unveiled Apple Watch on Tuesday after several months of hype, however the reaction in the tech world has been largely ho-hum, if not outright disappointment.
By Priya Anand, MarketWatch
ApplePay, the mobile payment system the Cupertino, Calif.-based tech giant (AAPL) unveiled Tuesday , could kill credit cards, but it also opens up a new window for criminals to hijack smartphones.
By Jon Friedman, MarketWatch
NEW YORK (MarketWatch) -- Right now, Facebook is flying so high that the worst thing you can say about the social media giant is that someday it may be remembered as an "Icarus stock."
It has soared so close to the sun that it may eventually have to start to plummet, simply from getting up so high.
By Claudia Assis, MarketWatch
SAN FRANCISCO (MarketWatch) -- Tesla Motors Inc. shares have been on a tear since CEO Elon Musk tweeted last week that new features or products will be unveiled Thursday, but are they a good buy at this point?
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.